Back to Search Start Over

Engraftment of Double Cord Blood Transplantation after Nonmyeloablative Conditioning with Escalated Total Body Irradiation Dosing to Facilitate Engraftment in Immunocompetent Patients.

Authors :
Brunstein CG
DeFor TE
Fuchs EJ
Karanes C
McGuirk JP
Rezvani AR
Eapen M
O'Donnell PV
Weisdorf DJ
Source :
Transplantation and cellular therapy [Transplant Cell Ther] 2021 Oct; Vol. 27 (10), pp. 879.e1-879.e3. Date of Electronic Publication: 2021 Jul 15.
Publication Year :
2021

Abstract

To improve accrual to a randomized clinical trial of double unrelated cord blood (dUCB) versus HLA-haploidentical bone marrow (haplo-BM) transplantation, patients with less previous therapy and potentially greater immunocompetence were enrolled. To reduce the risk of graft rejection, patients randomized to receive dUCB received a higher dose of total body irradiation (TBI) (300 cGy versus 200 cGy). In this study, we investigated whether the inclusion of recipients of 300 cGy TBI influenced the trial outcomes. This was a secondary analysis of dUCB recipients, 161 who received TBI 200 cGy and 18 who received TBI 300 cGy. Fine and Gray regression was used to evaluate the effect of TBI dose on relapse and nonrelapse mortality (NRM). Cox regression was used for evaluation of neutrophil engraftment and overall survival. Patient characteristics were similar in the 2 TBI dose subgroups. The probability of neutrophil engraftment was 100% for patients who received TBI 300 cGy versus 91% (95% confidence interval, 86% to 95%) for those who received TBI 200 cGy (P = .64), which was similar after regression analysis adjusting for age, total infused nucleated cell dose, HLA matching to the patient, and comorbidity score. We also investigated whether the lower survival probability and higher cumulative incidence of NRM observed in the dUCB arm of BMT CTN 1101 could be influenced by the TBI 300 cGy patient subset. There was no significant difference in the 1-year incidences of NRM and relapse or in 1-year survival, even after adjustment in multivariate analysis. Patients in BMT CTN 1101 who received TBI 300 cGy and 200 cGy had similar engraftment and early mortality. We conclude that inclusion of a modified regimen for dUCB transplantation had no demonstrable influence on this large randomized trial.<br /> (Copyright © 2021. Published by Elsevier Inc.)

Details

Language :
English
ISSN :
2666-6367
Volume :
27
Issue :
10
Database :
MEDLINE
Journal :
Transplantation and cellular therapy
Publication Type :
Academic Journal
Accession number :
34273598
Full Text :
https://doi.org/10.1016/j.jtct.2021.07.006